Antibody dependency in cancer refers to the reliance on monoclonal antibodies or other antibody-based therapies to target and treat cancer cells. These therapies leverage the immune system's natural ability to identify and destroy malignant cells. Monoclonal antibodies are designed to bind to specific proteins on the surface of cancer cells, marking them for destruction by the immune system or directly inhibiting their growth.
